Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Mar 14 04:00PM ET
22.80
Dollar change
+0.18
Percentage change
0.80
%
CategoryUS Equities - Factor & Thematic Asset TypeEquities (Stocks) TagsDeveloped Return% 1Y- Shs Outstand Perf Week1.02%
SponsorF/m Investments ETF Type Tagsequity Return% 3Y- Total Holdings32 Perf Month-10.99%
Fund Family Bond Type Tagsinnovation Return% 5Y- AUM49.83M Perf Quarter-10.89%
Index- Average Maturity Tagshealthcare Return% 10Y NAV% Perf Half Y-
Index Weighting Commodity Type Tagsbiotechnology Return% SI NAV/sh Perf Year-
Active/Passive Quant Type Tagsmedical Flows% 1M3.42% 52W Range21.91 - 27.76 Perf YTD-2.53%
Dividend TTM- ESG Type Tagspharmaceutical Flows% 3M5.70% 52W High-17.88% Beta-
Dividend Ex-Date- Dividend Type Sector/Theme Flows% YTD5.75% 52W Low4.05% ATR (14)0.54
Expense0.54% Structure Type Region Flows% 1Y RSI (14)38.02 Volatility0.96% 1.70%
Option/ShortNo / Yes Growth/Value Dev/Emerg Flows% 3Y Rel Volume1.26 Prev Close22.62
Inverse/Leveraged Market Cap Currency Flows% 5Y Avg Volume3.58K Price22.80
SMA20-4.70% SMA50-7.59% SMA200-8.73% Trades Volume4,524 Change0.80%
F/m Emerald Life Sciences Innovation ETF seeks long-term capital appreciation. The fund is an actively managed exchange-traded fund ("ETF") and invests primarily in equity securities of life science companies selected by Emerald Mutual Fund Advisers Trust, the fund's investment sub-adviser, under the supervision of the adviser. Under normal market conditions, the fund invests at least 80% of its net assets in equity securities issued by life science companies demonstrating innovation.